The 'responsive and pragmatic' team at DLA Piper leverages the firm's international network of offices to act for global pharma companies in a range of matters. Marco de Morpurgo divides his time between the Rome and Brussels offices, and is well versed in assisting with market access issues, advertising matters and product classification cases; he co-heads the practice with Joost Haans. Jean-Christophe Top joined the team in January 2024.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘The DLA team is responsive and pragmatic. Because of their global reach, they are able to act as a trusted partner for a wide range of matters in various jurisdictions. ’
‘Kristof De Vulder is very approachable, able to place himself in the client's position and provide valuable and actionable advice.’
Kernmandanten
- Acadia Pharmaceuticals
- Eqology
- Guerbet
- Intra-Cellular Therapies
- IVC Evidensia
- NeuroTrauma Sciences
- NewLeaf
- Nipro
- Owkin
- Phuse
Highlight-Mandate
- Assisting Nipro with a broad range of matters, including research, distribution and manufacturing contracts, compliance issues and packaging issues.
- Advising Acadia Pharmaceutical on its entrance into the European market.
Anwält*innen
Praxisleitung
Marco de Morpurgo; Joost Haans
Weitere Kernanwält*innen
Kristof De Vulder; Jean-Christophe Top